Page last updated: 2024-09-04

1,2-bis(5-amidino-2-benzimidazolyl)ethane and cycloguanil

1,2-bis(5-amidino-2-benzimidazolyl)ethane has been researched along with cycloguanil in 1 studies

Compound Research Comparison

Studies
(1,2-bis(5-amidino-2-benzimidazolyl)ethane)
Trials
(1,2-bis(5-amidino-2-benzimidazolyl)ethane)
Recent Studies (post-2010)
(1,2-bis(5-amidino-2-benzimidazolyl)ethane)
Studies
(cycloguanil)
Trials
(cycloguanil)
Recent Studies (post-2010) (cycloguanil)
6002311637

Protein Interaction Comparison

ProteinTaxonomy1,2-bis(5-amidino-2-benzimidazolyl)ethane (IC50)cycloguanil (IC50)
cGMP-dependent 3',5'-cyclic phosphodiesteraseHomo sapiens (human)5.8
Bifunctional dihydrofolate reductase-thymidylate synthasePlasmodium falciparum K12.985
Dihydrofolate reductasePneumocystis carinii0.45
Dihydrofolate reductaseRattus norvegicus (Norway rat)0.11

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Queener, SF1

Reviews

1 review(s) available for 1,2-bis(5-amidino-2-benzimidazolyl)ethane and cycloguanil

ArticleYear
New drug developments for opportunistic infections in immunosuppressed patients: Pneumocystis carinii.
    Journal of medicinal chemistry, 1995, Nov-24, Volume: 38, Issue:24

    Topics: Animals; Drug Design; Humans; Immunosuppression Therapy; Molecular Structure; Opportunistic Infections; Pneumonia, Pneumocystis; Structure-Activity Relationship

1995